entertainment -WSS

entertainment

author：knowledge 2025-09-05 13:46:17 - browse：5791

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Biohaven protein

WSS

Addiction doctors spar with methadone clinics over legislation

How neuroscience research could help beat back brain cancer

Addiction doctors spar with methadone clinics over legislation

Kidney transplant patients stopped immunosuppressants in trial

Inari Medical to buy amputation prevention company LimFlow

Prosthetic arm enables patients to feel the objects they grip

entertainment

entertainment

hotspot

New air purifier tech could be key to improving indoor air quality

Latest bird flu infection made farmworker sicker than earlier cases

Heart attack and stroke risk calculators need revising

Gene therapy’s promise and the high cost of hope

Drug repurposing or repositioning? The language matters

Report: NIH

Moonlake's readout produced a cash windfall. Risks remain

Biohaven protein

What does generative AI mean for health care? We asked experts

Kidney transplant patients stopped immunosuppressants in trial

focus

Explaining an after

Medicare proceeds with plan to claw back hospital funds

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

How to convince healthy people to buy insurance

Bill would allow buprenorphine prescription for addiction via telehealth

Latest bird flu infection made farmworker sicker than earlier cases

leisure time

leisure time

entertainment

hotspot